Narmada Shenoy

17.5k total citations
17 papers, 990 citations indexed

About

Narmada Shenoy is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Narmada Shenoy has authored 17 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Narmada Shenoy's work include Chemical Synthesis and Analysis (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Narmada Shenoy is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Narmada Shenoy collaborates with scholars based in United States, India and Israel. Narmada Shenoy's co-authors include Gerald McMahon, Julie M. Cherrington, May Chien, Cheryl A. London, Dirk B. Mendel, Laura K. Shawver, Cho Tang, Peter Vajkoczy, Axel Ullrich and Li Sun and has published in prestigious journals such as Blood, Journal of Agricultural and Food Chemistry and Journal of Chromatography A.

In The Last Decade

Narmada Shenoy

17 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Narmada Shenoy United States	11	532	299	240	145	138	17	990
Barbara Peter Austria	21	417 0.8×	132 0.4×	119 0.5×	72 0.5×	392 2.8×	48	1.1k
Paula Vainio Finland	15	640 1.2×	317 1.1×	230 1.0×	275 1.9×	82 0.6×	26	1.1k
Martin L. Campbell United States	13	805 1.5×	403 1.3×	515 2.1×	232 1.6×	116 0.8×	18	1.4k
Mathewos Tessema United States	21	987 1.9×	258 0.9×	312 1.3×	398 2.7×	147 1.1×	38	1.4k
Rong‐Yaun Shyu Taiwan	20	491 0.9×	156 0.5×	173 0.7×	128 0.9×	208 1.5×	40	1.1k
Yvonne Y. Li United States	15	811 1.5×	207 0.7×	462 1.9×	317 2.2×	191 1.4×	32	1.4k
Joseph A. Rafferty United Kingdom	22	1.1k 2.1×	68 0.2×	320 1.3×	419 2.9×	94 0.7×	47	1.5k
Alessio Giubellino United States	21	605 1.1×	164 0.5×	329 1.4×	308 2.1×	128 0.9×	77	1.3k
Deborah J. Mays United States	13	1.1k 2.0×	108 0.4×	717 3.0×	151 1.0×	143 1.0×	14	1.5k
Denis M. Collins Ireland	20	479 0.9×	210 0.7×	671 2.8×	156 1.1×	139 1.0×	53	1.2k

Countries citing papers authored by Narmada Shenoy

Since Specialization

Citations

This map shows the geographic impact of Narmada Shenoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narmada Shenoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narmada Shenoy more than expected).

Fields of papers citing papers by Narmada Shenoy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narmada Shenoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narmada Shenoy. The network helps show where Narmada Shenoy may publish in the future.

Co-authorship network of co-authors of Narmada Shenoy

This figure shows the co-authorship network connecting the top 25 collaborators of Narmada Shenoy. A scholar is included among the top collaborators of Narmada Shenoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narmada Shenoy. Narmada Shenoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Jahagirdar, Ravi, Sarah Attwell, Suzana Marušić, et al.. (2017). RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease. Molecular Pharmacology. 92(6). 694–706. 48 indexed citations

Sistla, Anand, et al.. (2008). Development of an intravenous formulation of SU010382 (prodrug of SU5416, an anti-angiogenesis agent).. PubMed. 62(3). 200–10. 6 indexed citations

Sistla, Anand, et al.. (2006). High-performance liquid chromatographic method for determination of reversible isomers of SU5416. Journal of Chromatography A. 1110(1-2). 73–80. 8 indexed citations

Sistla, Anand & Narmada Shenoy. (2005). Reversible Z-E Isomerism and Pharmaceutical Implications for SU5416. Drug Development and Industrial Pharmacy. 31(10). 1001–1007. 9 indexed citations

Sistla, Anand, et al.. (2004). Powder‐in‐Bottle Formulation of SU011248. Enabling Rapid Progression into Human Clinical Trials. Drug Development and Industrial Pharmacy. 30(1). 19–25. 13 indexed citations

London, Cheryl A., Alison L. Hannah, May Chien, et al.. (2003). Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies.. PubMed. 9(7). 2755–68. 220 indexed citations

Liao, Albert Taiching, May Chien, Narmada Shenoy, et al.. (2002). Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors. Blood. 100(2). 585–593. 95 indexed citations

Laird, Alexander, Peter Vajkoczy, Laura K. Shawver, et al.. (2000). SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.. PubMed. 60(15). 4152–60. 402 indexed citations

Powell, Thomas, Hannah Ben‐Bassat, Benjamin Klein, et al.. (1999). Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitors. British Journal of Dermatology. 141(5). 802–810. 39 indexed citations

10.

Shenoy, Narmada, John E. Shively, & Jerome M. Bailey. (1993). Studies in C-terminal sequencing: New reagents for the synthesis of peptidylthiohydantoins. Journal of Protein Chemistry. 12(2). 195–205. 7 indexed citations

11.

Shenoy, Narmada, Jerome M. Bailey, & John E. Shively. (1992). Carboxylic acid‐modified polyethylene: A novel support for the covalent immobilization of polypeptides for C‐terminal sequencing. Protein Science. 1(1). 58–67. 16 indexed citations

12.

Bailey, Jerome M., Narmada Shenoy, Michael Ronk, & John E. Shively. (1992). Automated carboxy‐terminal sequence analysis of peptides. Protein Science. 1(1). 68–80. 21 indexed citations

13.

Bailey, Jerome M., et al.. (1992). Automated carboxy‐terminal sequence analysis of peptides and proteins using diphenyl phosphoroisothiocyanatidate. Protein Science. 1(12). 1622–1633. 21 indexed citations

14.

Shenoy, Narmada, et al.. (1992). Characterization of potentially mutagenic products from the nitrosation of piperine. Cancer Letters. 64(3). 235–239. 8 indexed citations

15.

Shenoy, Narmada, et al.. (1992). Inhibitory effect of diet related sulphydryl compounds on the formation of carcinogenic nitrosamines. Cancer Letters. 65(3). 227–232. 55 indexed citations

16.

Shenoy, Narmada, et al.. (1992). Nitrosation of piperine using different nitrosating agents: characterization and mutagenicity of the products. Journal of Agricultural and Food Chemistry. 40(11). 2211–2215. 3 indexed citations

17.

Shenoy, Narmada, et al.. (1989). Effect of certain plant phenolics on nitrosamine formation. Journal of Agricultural and Food Chemistry. 37(3). 721–725. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact